Structural and functional characterization of USP47 reveals a hot spot for inhibitor design
Sang Chul Shin1,2, Jinyoung Park1,3, Kyung Hee Kim1
1Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
Abstract:
USP47 is widely involved in tumor development, metastasis, and other processes while performing a more regulatory role in inflammatory responses, myocardial infarction, and neuronal development. In this study, we investigate the functional and biochemical properties of USP47, whereby depleting USP47 inhibited cancer cell growth in a p53-dependent manner-a phenomenon that enhances during the simultaneous knockdown of USP7. Full-length USP47 shows higher deubiquitinase activity than the catalytic domain. The crystal structures of the catalytic domain, in its free and ubiquitin-bound states, reveal that the misaligned catalytic triads, ultimately, become aligned upon ubiquitin-binding, similar to USP7, thereby becoming ready for catalysis. Yet, the composition and lengths of BL1, BL2, and BL3 of USP47 differ from those for USP7, and they contribute to the observed selectivity. Our study provides molecular details of USP47 regulation, substrate recognition, and the hotspots for drug discovery by targeting USP47.
Insights
Ubiquitin-specific protease 47 (USP47) regulates cancer cell growth via p53. Its structure reveals how USP47 binds ubiquitin, offering potential drug targets for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ubiquitin-specific protease 47 (USP47) plays a role in tumor development and metastasis.
- USP47 also regulates inflammatory responses, myocardial infarction, and neuronal development.
Purpose of the Study:
- To investigate the functional and biochemical properties of USP47.
- To elucidate the molecular mechanisms underlying USP47's activity and substrate recognition.
Main Methods:
- Depletion of USP47 in cancer cells.
- Biochemical assays to measure deubiquitinase activity.
- Crystal structure determination of USP47 catalytic domain (free and ubiquitin-bound states).
Main Results:
- USP47 depletion inhibited cancer cell growth in a p53-dependent manner, enhanced by USP7 knockdown.
- Full-length USP47 exhibited higher deubiquitinase activity than its catalytic domain.
- Crystal structures revealed ubiquitin-induced catalytic triad alignment in USP47, similar to USP7.
- Differences in BL1, BL2, and BL3 regions contribute to USP47's selectivity.
Conclusions:
- USP47's activity is regulated by ubiquitin binding, with structural features dictating substrate selectivity.
- Understanding USP47's molecular regulation provides insights into cancer development.
- USP47 represents a potential target for novel cancer drug discovery.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Ligand Binding and Linkage
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Protein-protein Interfaces
